Phoenix Holdings Ltd. Orgenesis Inc. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$4.77 - $8.08 $3.54 Million - $6 Million	-742,041 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$4.4 - $5.63 $12,531 - $16,034	-2,848 Reduced 0.38%	742,041 $3.33 Million
Q3 2020 Nov 10, 2020	SELL	$4.75 - $5.99 $94,710 - $119,434	-19,939 Reduced 2.61%	744,889 $3.54 Million
Q2 2020 Aug 10, 2020	SELL	$3.6 - $7.84 $1.53 Million - $3.34 Million	-425,898 Reduced 35.77%	764,828 $4.42 Million
Q1 2020 May 20, 2020	BUY	$2.76 - $5.44 $3.11 Million - $6.13 Million	1,126,726 Added 1760.51%	1,190,726 $4.42 Million

Q3 2019 Nov 18, 2019	BUY	$4.18 - $4.85 $267,520 - $310,400	64,000 New	64,000 $273,000

1.63M

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $16.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.